课题基金 / 基金详情

Physiological roles of cell surface ecto-enzymes

Physiological roles of cell surface ecto-enzymes
细胞表面胞外酶的生理作用
批准号:
11694249
负责人:
KATADA Toshiaki
金额:
$4.42万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

KATADA Toshiaki的其他基金

相似基金

相关文献

中文摘要
翻译
维甲酸(RA)诱导HL-60细胞产生的外源型NAD酶活性是由CD 38引起的,CD 38的氨基酸序列与拟南芥ADP-核糖基环化酶同源。CD 38不仅催化NAD^+的水解,而且催化环ADP-核糖(cADPR)的形成和水解,后者是细胞内Ca ^2+库释放Ca^2+的新型介质或调节剂。本研究对CD 38及其相关胞外酶PC-1的功能和性质进行了研究。1. CD 38能够水解除NAD^+以外的许多化合物的N-糖苷键。2. CD 38大量存在于大鼠星形胶质细胞中,除了淋巴细胞,和细胞表面的CD 38被迅速灭活后,与酶底物孵育。3.可溶性和膜结合形式的PC-1,这已诱导在人Jurkat T细胞培养后与cAMP类似物,进行了鉴定和表征的酶和结构。4.两种PC-1分子均具有磷酸二酯酶/焦磷酸酶活性,可溶性PC-1的酶活性可用于寻找与其相互作用的分子。5.细胞外基质中的糖胺聚糖如肝素和硫酸乙酰肝素能够与PC-1结合,并以与酶底物竞争的方式抑制其磷酸二酯酶活性。6.人PC-1的同源物也存在于秀丽隐杆线虫中,并且它具有磷酸二酯酶/焦磷酸酶活性。酶活性定位于细胞表面。因此,PC-1可能作为粘附分子与细胞外基质中的糖胺聚糖结合。
英文摘要
Ecto-form NADase activity induced by retinoic acid (RA) in human HL-60 cells is due to CD38, which has an amino acid sequence homologous to Aplysia ADP-ribosyl cyclase. CD38 catalyzes not only the hydrolysis of NAD^+, but also the formation and hydrolysis of cyclic ADP-ribose (cADPR), that is a novel mediator or modulator of Ca^<2+> release from intracellular Ca^<2+> stores. In the present study, we investigated the functions and properties of CD38 and its related ecto-enzyme, PC-1. 1. CD38 was capable of hydrolyzing the N-glycoside bond of many compounds other than NAD^+. 2. CD38 was abundantly present in rat astrocytes in addition to lymphocytes, and the cell-surface CD38 was rapidly inactivated upon incubation with the enzyme substrates. 3. Soluble and membrane-bound forms of PC-1, which had been induced in human Jurkat T cells upon culture with a cAMP analog, were identified and characterized enzymatically and structurally. 4. Both PC-1 molecules possessed phosphodiesterase/pyrophosphatase activity, and the enzymic activity of soluble PC-1 could be utilized to search for its interacting molecules. 5. Glycosaminoglycans, such as heparin and heparan sulfate in extracellular matrix, were capable of binding to PC-1 and inhibited its phosphodiesterase activity in a manner competing with the enzyme substrates. 6. A homologue of human PC-1 was also present in C.elegans, and it possessed phosphodiesterase/pyrophosphatase activity. The enzymic activity was localized in the cell surface. Thus, PC-1 may function as an adhesion molecule to associate with glycosaminoglycans in extracellular matrix.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
T.Katada, et al.: "Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors."Chemistry and Physics of Lipids. 98. 79-86 (1999)
T.Katada 等人:“通过 G 蛋白偶联和酪氨酸激酶相关受体协同激活磷酸肌醇 3-激酶家族。”脂质化学和物理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
堅田利明(分担): "シグナル伝達 総集編(竹縄忠臣 編)"羊土社. 235 (1999)
Toshiaki Katata(贡献者):“信号传输编译(竹轮忠臣编辑)”Yodosha 235(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Identification of signaling pathways involved in fungal pathogenicity and search for novel targets for antifungal drugs
    • 批准号:
      20K06550
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      KATADA Toshiaki
    • 依托单位:
    Nutrient response mediated by a TRIM-NHL protein
    A novel signal transduction pathway which regulates the structure of P-body and the dynamics of ARE-mRNAs
    • 批准号:
      22659015
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.92万
    • 财政年份:
      2010
    • 负责人:
      KATADA Toshiaki
    • 依托单位:
    Regulation of intracellular vesicle transport by small GTPase cycles
    • 批准号:
      20247011
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.46万
    • 财政年份:
      2008
    • 负责人:
      KATADA Toshiaki
    • 依托单位:
    国内基金
    海外基金
    力学刺激调控巨噬细胞CD38/NAD+SIRT1轴促进肩袖损伤修复术后腱骨愈合的机制与验证研究
    • 批准号:
      JCZRLH202602006
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    胆管癌中CD38介导的NAD+耗竭导致SIRT1失活并促进FXR高乙酰化修饰的代谢机制研究
    ABCA1/CD38/NAD+通路诱导巨噬细胞衰老促进子宫内膜异位症进展的机制研究
    • 批准号:
      2026JJ80446
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      曾文
    • 依托单位:
    基于虚拟筛选的CD38小分子抑制剂T67751在鼻咽癌中的作用及其机制研究
    • 批准号:
      2026JJ81933
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      唐婧琼
    • 依托单位: